---
figid: PMC9266941__ijms-23-06983-g001
figtitle: Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic
  Ossification
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
- Staphylococcus aureus
- Adenoviridae
pmcid: PMC9266941
filename: ijms-23-06983-g001.jpg
figlink: /pmc/articles/PMC9266941/figure/ijms-23-06983-f001/
number: F1
caption: BMP receptor activation and downstream signalling and its antagonism through
  the Activin A pathway. In the canonical pathway, SMAD1/5/8 is activated and interacts
  with SMAD4 to promote expression of target genes that induce bone formation. In
  the non-canonical SMAD pathway, p38 MAPK, ERK1/2 and/or JNK are activated to promote
  the expression of osteogenic target genes. BMP signalling is antagonised by the
  binding of Activin A to its receptor complex to initiate SMAD2/3 signalling that
  acts to suppress BMP target gene transcriptional activation.
papertitle: Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic
  Ossification.
reftext: Favour Felix-Ilemhenbhio, et al. Int J Mol Sci. 2022 Jul;23(13):6983.
year: '2022'
doi: 10.3390/ijms23136983
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: heterotopic ossification | genetics | bone morphogenetic protein | activin
  A/ALK2 | retinoic acid receptor | Hoxa11+ mesenchymal stromal cells
automl_pathway: 0.9692787
figid_alias: PMC9266941__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Danio rerio
redirect_from: /figures/PMC9266941__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9266941__ijms-23-06983-g001.html
  '@type': Dataset
  description: BMP receptor activation and downstream signalling and its antagonism
    through the Activin A pathway. In the canonical pathway, SMAD1/5/8 is activated
    and interacts with SMAD4 to promote expression of target genes that induce bone
    formation. In the non-canonical SMAD pathway, p38 MAPK, ERK1/2 and/or JNK are
    activated to promote the expression of osteogenic target genes. BMP signalling
    is antagonised by the binding of Activin A to its receptor complex to initiate
    SMAD2/3 signalling that acts to suppress BMP target gene transcriptional activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BMPR2
  - BMP2
  - SMAD1
  - GARS1
  - SMAD5
  - SMAD9
  - BMP1
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF1
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
  - SMAD4
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - INHBA
  - INHBB
  - ACVR2B
  - SMAD2
  - Bmpr2
  - Bmp2
  - Smad1
  - Smad5
  - Smad9
  - Smad4
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Mapk3
  - Mapk1
  - Mapk8
  - Acvr2a
  - Acvr2b
  - Smad2
  - bmp2a
  - bmp2b
  - smad1
  - smad5
  - smad4a
  - smad4b
  - mapk14a
  - mapk3
  - mapk8b
  - acvr2ba
  - smad2
---
